Nurse and physician inter-rater agreement of three performance status measures in palliative care outpatients

Supportive Care in Cancer

Volumn 18, Issue 5, 2010, Pages 609-616

  Zimmermann, Camilla ^a,c   Burman, Debika ^c   Bandukwala, Shazeen ^c   Seccareccia, Dori ^a,c   Kaya, Ebru ^c   Bryson, John ^c   Rodin, Gary ^b,c   Lo, Christopher ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Eastern Cooperative oncology group; Inter rater agreement; Karnofsky; Outpatient clinic; Palliative; Performance status

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; CORRELATION ANALYSIS; EASTERN COOPERATIVE ONCOLOGY GROUP; FEMALE; HUMAN; INTERRATER RELIABILITY; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; NURSE; OUTPATIENT; PALLIATIVE SCALE; PALLIATIVE THERAPY; PERFORMANCE MEASUREMENT SYSTEM; PHYSICIAN; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM;

ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; CANCER CARE FACILITIES; FEMALE; HUMANS; KARNOFSKY PERFORMANCE STATUS; MALE; MIDDLE AGED; NURSES; OBSERVER VARIATION; ONTARIO; PALLIATIVE CARE; PHYSICIANS; YOUNG ADULT;

EID: 77953617195     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-009-0700-9     Document Type: Article

References (50)

1. Anderson F, Downing GM, Hill J, Casorso L, Lerch N (1996) Palliative performance scale (PPS): A new to ol. J Palliat Care 12:5-11
2. Ando M, Ando Y, Hasegawa Y, Shimokata K, Minami H, Wa KaiK, Ohno Y, Sa Kai S (2001) Prognostic value of performance statusassessed by patients the mselves, nurses, and oncologists in advanced non-small cell lung cancer. Br J Cancer 85:1634-1639
3. Armitage P, Berry G, Matthews J (2002) Statistical methods in medical research. Blackwell, Oxford
4. Bachelot T, Ray-Coquard I, Catimel G, Ardiet C, Guastalla JP,Dumortier A, Chauvin F, Droz JP, Philip T, Clavel M (2000) Multivariable analysis of prognostic facto rs for to xicity andsurvival for patients enrolled in phase I clin ical trials. Annoncol11:151-156
5. Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillank (1991) the Edmonton sympto massessment system (ESAS): A simplemethod forthe assessment of palliative care patients. J Palliat Care 7:6-9
6. Campos S, Zhang L, Sinclair E, Tsao M, Barnes EA, Danjoux C,Sahgal A, Goh P, Culleton S, Mitera G, Chowe (2009) the Palliative performance scale: Exam in ing its in ter-rater reliability in anoutpatient palliative radiationoncology clin ic. Support Care Cancer 17:685-690
7. Carlson LE, Angen M, Cullum J, Goodey E, Koopmans J,Lamont L, MacRae JH, Martin M, Pelletier G, Robinson J,Simpson JS, Speca M, Tillotson L, Bultz BD (2004) High levels of untreated distress and fatigue in cancer patients. Br J Cancer90:2297-2304
8. Casarett DJ, Fishman JM, Lu HL, O'Dwyer PJ, Barg FK, NaylorMD, Asch DA (2009) the terrible choice: Re-evaluat ing hospiceeligibility criteria for cancer. J Clinoncol 27:953-959
9. Chang VT, Hwang SS, Feuerman M (2000) Validationof the Edmonton sympto m assessment scale. Cancer 88:2164-2171
10. Cheung WY, Barmala N, Zarinehbaf S, Rodin G, Le LW,Zimmermann C (2009) the associationof physical and psychologicalsympto m burden with time to death among palliativecancer outpatients. J Pa in Sympto m Manage 37:297-304
11. Chow E, Abdolell M, Panzarella T, Harris K, Bezja K A, Warde P,Tannock I (2008) Predictive model for survivalin patients with advanced cancer. J Clinoncol 26:5863-5869
12. Cohen J (1960) A coefficient of agreement for nom in al scales.Educ Psychol Meas 20:37-46
13. Cohen J (1968) Weighted kappa: Nom in al scale agreement with provision for scale disagreement or partial credit. Psychol Bull70:213-220
14. Conill C, Verger E, Salamero M (1990) Performance statusassessment in cancer patients. Cancer 65:1864-1866
15. Currow DC, Eagar K, Aoun S, Fildes D, Yates P, Kristjanson LJ (2008) Is it feasible and desirable to collect voluntarily quality andoutcome data nationally in palliative oncology care? J Clinoncol26:3853-3859
16. Davis E, Nicolas C, Waters E, Cook K, Gibbs L, Gosch A,Ravens-Sieberer U (2007) Parent-proxy and child self-reportedhealth-related quality of life: Us ing qualitative methods to expla in the discordance. Qual Life Res 16:863-871
17. de Borja MT, Chow E, Bovett G, Davis L, Gillies C (2004) the correlation among patients and health care pr of essionals in assess ing functional status us ing the karnof sky and easterncooperative oncology group performance status scales. SupportCancer ther 2:59-63
18. Downing M, Lau F, Lesperance M, Karlson N, Shaw J,Kuziemsky C, Bernard S, Hanson L, Olajide L, Head B, RitchieC, Harrold J, Casarett D (2007) Meta-analysis of survivalprediction with palliative performance scale. J Palliat Care23:245-252
19. Fainsinger RL, Demoissac D, Cole J, Mead-Wood K, Lee E (2000) Home versus hospice in patient care: Discharge characteristics of palliative care patients in an acute care hospital. J Palliat Care 16:29-34
20. Fayers PM, Aaronsonn K., Bjordal K, Groenvold M, Curran D,Bottomley A (2001) EORTC QLQ-C30 scor ing manual, 3rd edn.EORTC Quality of Life Group, Brussels
21. Fleiss JL, Levin BA, Paik MC (2003) Statistical methods for ratesand proportions, 3rd edn. Wiley- in terscience, Hoboken
22. Follwell M, Burman D, Le LW, Wa Kimoto K, Seccareccia D,Bryson J, Rodin G, Zimmermann C (2009) Phase II study of anoutpatient palliative care in tervention in patients with metastaticcancer. J Clinoncol 27:206-213
23. Glare P, Virik K, Jones M, Hudson M, Eychmuller S, SimesJ, Christa Kis N (2003) A systematic review of physicians'survival predictions in term in ally ill cancer patients. BMJ327:195
24. Harrold J, Rickerson E, Carroll JT, McGrath J, Morales K, KapoJ, Casarett D (2005) Is the palliative performance scale a usefulpredicto r of mortality in a heterogeneous hospice population? J Palliat Med 8:503-509
25. Head B, Ritchie CS, Smoot TM (2005) Prognostication in hospicecare: Can the palliative performance scale help? J Palliat Med8:492-502
26. Ho F, Lau F, Downing MG, Lesperance M (2008) A reliabilityand validity study of the palliative performance scale. BMC Palliat Care 7:10
27. Husain AF, Stewart K, Arseneault R, Moineddin R, Cellarius V,Librach SL, Dudgeon D (2007) Women experience higher levels of fatigue than men at the end of life: A longitud in al homepalliative care study. J Pa in Sympto m Manage 33:389-397
28. Janisch L, Mick R, Schilsky RL, Vogelzang NJ, O'Brien S, KutM, Ratain MJ (1994) Prognostic facto rs for survivalin patientstreated in phase I clin ical trials. Cancer 74:1965-1973
29. Jordhoy MS, Fayers P, Loge JH, Saltnes T, Ahlner-Elmqvist M,Kaasa S (2001) Quality of life in advanced cancer patients: The impact of sociodemographic and medical characteristics. Br J Cancer 85:1478-1485
30. Kaasa S, Loge JH (2003) Quality of life in palliative care:pr in ciples and practice. Palliat Med 17:11-20
31. Karnofsky DA, Burchenal JH (1949) the clin ical evaluationof chemotherapeutic agents in cancer. in : MacLeod CM (ed) Evaluationof chemotherapeutic agents in cancer. ColumbiaUniversity Press, New York, pp 191-205
32. KFL&A Palliative Care in tegration Project (2003) Sympto mmanagement guidelines. Queen's University, K in gston
33. Lau F, Downing GM, Lesperance M, Shaw J, Kuziemsky C (2006) Use of palliative performance scale in end- of -life prognostication.J Palliat Med 9:1066-1075
34. Lenz HJ, Lee FC, Haller DG, Singh D, Benson AB III, StrumbergD, Yanagihara R, Yao JC, Phan AT, Ajani JA (2007) Extendedsafety and efficacy data on S-1 plus cisplat in in patients with untreated, advanced gastric carc inoma in a multicenter phase IIstudy. Cancer 109:33-40
35. Maltoni M, Caraceni A, Brunelli C, Broeckaert B, Christa Kis N,Eychmueller S, Glare P, Nabal M, Vigano A, Larkin P, De Connof , Hanks G, Kaasa S (2005) Prognostic facto rs in advanced cancerpatients: Evidence-based clin ical recommendations-A study by the Steer ing Committee of the European Association for PalliativeCare. J Clinoncol 23:6240-6248
36. Mor V, Laliberte L, Morris JN, Wiemann M (1984) the Karnofsky performance status scale. An exam in ationof itsreliability and validity in a research sett in g. Cancer 53:2002-2007
37. OkenMM, Creech RH, to rmey DC, Horton J, Davis TE,McFaddenET, Carbone PP (1982) to xicity and response criteria of the EasternCooperative Oncology Group. Am J Clinoncol 5:649-655
38. Oki Y, Pro B, Fayad LE, Romaguera J, Samaniego F, Hagemeister F,Neelapu S,McLaughlin P, Goy A, Younes A (2008) Phase 2 study of gemcitab ine in comb in ation with rituximab in patients with recurrento r refracto ry Hodgk in lymphoma. Cancer 112:831-836
39. Olajide O, Hanson L, Usher BM, Qaqish BF, Schwartz R, BernardS (2007) Validationof the palliative performance scale in the acute tertiary care hospital sett in g. J Palliat Med 10:111-117
40. Patel SH, Ajlouni M, Chapman R, Lu M, Movsas B, Kim JH (2007) A prospective phase II study of in duction carboplat in andv inorelb ine followed by concomitant to potecan and acceleratedradiotherapy (ART) in locally advanced non-small cell lungcancer (NSCLC). J Thorac Oncol 2:831-837
41. Philip J, Smith WB, Craft P, Lickiss N (1998) Concurrent validity of the modified Edmonton sympto m assessment system with therotterdam sympto m checklist and the brief pa in in vento ry.Support Care Cancer 6:539-541
42. Riechelmann RP, Krzyzanowska MK, O'carroll A, Zimmermann C (2007) Sympto m and medication pr of iles among cancer patientsattenDing a palliative care clin ic. Support Care Cancer 15:1407-1412
43. Roila F, Lupattelli M, Sassi M, Basurto C, Bracarda S,Picciafuoco M, Boschetti E, Milella G, Ballatori E, tonato M (1991) in tra and in terobserver variability in cancer patients'performance status assessed accorDing to Karnofsky and ECOGscales. Annoncol 2:437-439
44. Schag CC, Heinrich RL, Ganz PA (1984) Karnofsky performancestatus revisited: Reliability, validity, and guidelines. J Clinoncol2:187-193
45. Siegel AB, Cohen EI, Ocean A, Lehrer D, Goldenberg A, KnoxJJ, Chen H, Clark-Garvey S, We in berg A, Mandeli J, Christo s P,Mazumdar M, Popa E, Brown RS Jr, Rafii S, Schwartz JD (2008) Phase II trial evaluat ing the clin ical and biologic effects of bevacizumab in unresectable hepato cellular carc inoma. J Clinoncol 26:2992-2998
46. Taylor AE, Olver in , Sivanthan T, Chi M, Purnell C (1999) Observer error in graDing performance status in cancer patients.Support Care Cancer 7:332-335
47. Webster K, Cella D, Yost K (2003) the functional assessment of chronic illness therapy (FACIT) measurement system: Properties,applications, and in terpretation. Health Qual Life Outcomes 1:79
48. Westerman MJ, the AM, Sprangers MA, Groen HJ, van der WG,Ha K T (2007) Small-cell lung cancer patients are just 'a little bit'tired: Response shift and self-presentation in the measurement of fatigue. Qual Life Res 16:853-861
49. Yates JW, Chalmer B, McKegney FP (1980) Evaluationof patients with advanced cancer us ing the Karnofsky performancestatus. Cancer 45:2220-2224
50. Zimmermann C, Seccareccia D, Clarke A, Warr D, Rodin G (2006) Br in g ing palliative care to a Canadian cancer center: The Palliative care program at Pr in cess Margaret Hospital. Support Care Cancer 14:982-987